1. Home
  2. NHS vs NERV Comparison

NHS vs NERV Comparison

Compare NHS & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuberger Berman High Yield Strategies Fund

NHS

Neuberger Berman High Yield Strategies Fund

HOLD

Current Price

$6.14

Market Cap

199.8M

Sector

Finance

ML Signal

HOLD

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.00

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHS
NERV
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.8M
210.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
NHS
NERV
Price
$6.14
$4.00
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
209.0K
124.8K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
13.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$1.57
52 Week High
$7.75
$12.46

Technical Indicators

Market Signals
Indicator
NHS
NERV
Relative Strength Index (RSI) 36.36 33.65
Support Level $6.13 $3.69
Resistance Level $6.54 $4.59
Average True Range (ATR) 0.06 0.39
MACD -0.02 0.00
Stochastic Oscillator 22.73 3.81

Price Performance

Historical Comparison
NHS
NERV

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: